Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cerebral Venous Sinus Thrombosis Associated With Sars-Cov-2; a Multinational Case Series Publisher Pubmed



Mowla A1 ; Shakibajahromi B2 ; Shahjouei S3 ; Borhanihaghighi A2 ; Rahimian N4 ; Baharvahdat H5 ; Naderi S6 ; Khorvash F7 ; Altafi D8 ; Ebrahimzadeh SA9 ; Farahmand G10 ; Vaghefi Far A10 ; Sharma VK11 ; Neshin SAS12 Show All Authors
Authors
  1. Mowla A1
  2. Shakibajahromi B2
  3. Shahjouei S3
  4. Borhanihaghighi A2
  5. Rahimian N4
  6. Baharvahdat H5
  7. Naderi S6
  8. Khorvash F7
  9. Altafi D8
  10. Ebrahimzadeh SA9
  11. Farahmand G10
  12. Vaghefi Far A10
  13. Sharma VK11
  14. Neshin SAS12
  15. Tsivgoulis G13, 14
  16. Zand R3, 14
Show Affiliations
Authors Affiliations
  1. 1. Division of Stroke and Endovascular Neurosurgery, Department of Neurological Surgery, Keck School of Medicine, University of Southern California, California, United States
  2. 2. Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  3. 3. Neurology Department, Neuroscience Institute, Geisinger Health System, PA, United States
  4. 4. Neurology Department, Yasrebi Hospital, Kashan, Iran
  5. 5. Division of Neuroendovascular Surgery, Department of Neurosurgery, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
  6. 6. Neurosurgery Department, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran
  8. 8. Department of Neurology, Alavi Hospital, Ardabil University of Medical Sciences, Ardabil, Iran
  9. 9. Department of Radiology, Yasrebi Hospital, Kashan, Iran
  10. 10. Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
  11. 11. Division of Neurology, National University Health System, School of Medicine, National University of Singapore, Singapore
  12. 12. Neuroscience Research Center, Guilan University of Medical Sciences, Guilan, Iran
  13. 13. Second Department of Neurology, National and Kapodistrian University of Athens, School of Medicine, “Attikon� University Hospital, Athens, Greece
  14. 14. Neurology Department, University of Tennessee Health Science Center, TN, United States

Source: Journal of the Neurological Sciences Published:2020


Abstract

Background: SARS-CoV-2 induced coagulopathy can lead to thrombotic complications such as stroke. Cerebral venous sinus thrombosis (CVST) is a less common type of stroke which might be triggered by COVID-19. We present a series of CVST cases with SARS-CoV-2 infection. Methods: In a multinational retrospective study, we collected all cases of CVST in SARS-CoV-2 infected patients admitted to nine tertiary stroke centers from the beginning of the pandemic to June 30th, 2020. We compared the demographics, clinical and radiological characteristics, risk factors, and outcome of these patients with a control group of non-SARS-CoV-2 infected CVST patients in the same seasonal period of the years 2012–2016 from the country where the majority of cases were recruited. Results: A total of 13 patients fulfilled the inclusion criteria (62% women, mean age 50.9 ± 11.2 years). Six patients were discharged with good outcomes (mRS ≤ 2) and three patients died in hospital. Compared to the control group, the SARS-CoV-2 infected patients were significantly older (50.9 versus 36.7 years, p < 0.001), had a lower rate of identified CVST risk factors (23.1% versus 84.2%, p < 0.001), had more frequent cortical vein involvement (38.5% versus 10.5%, p: 0.025), and a non-significant higher rate of in-hospital mortality (23.1% versus 5.3%, p: 0.073). Conclusion: CVST should be considered as potential comorbidity in SARS-CoV-2 infected patients presenting with neurological symptoms. Our data suggest that compared to non-SARS-CoV-2 infected patients, CVST occurs in older patients, with lower rates of known CVST risk factors and might lead to a poorer outcome in the SARS-CoV-2 infected group. © 2020
Other Related Docs
16. Pediatric Endocrinopathies Related to Covid-19: An Update, World Journal of Pediatrics (2023)
17. Anticoagulant Therapy in Covid-19: A Narrative Review, Clinical and Translational Science (2023)
29. Neurological Involvements in Covid-19: A Hospital-Based Study, Iranian Journal of Child Neurology (2023)
40. Covid-19 in Patients With Hypertension, Advances in Experimental Medicine and Biology (2021)
46. Immunosenescence and Inflamm-Ageing in Covid-19, Ageing Research Reviews (2023)
47. Covid-19 Infection and Stroke Risk, Reviews in the Neurosciences (2021)